SCINAI IMMUNOTHERAPEUTICS LTD. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of -$1.76 million as of 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Balance Sheet › Equity
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2023-04-17
- 2022-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$1.76M.
- 2021-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $982.00K.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2022-12-31 | -$1.76M 10-K · filed 2023-04-17 |
| 2021-12-31 | $982.00K 10-K · filed 2023-04-17 |